课题基金 / 基金详情

MECHANISM OF SERINE/THREONINE KINASE SURVIVAL PROMOTION

MECHANISM OF SERINE/THREONINE KINASE SURVIVAL PROMOTION
丝氨酸/苏氨酸激酶存活促进机制
批准号:
2858474
负责人:
Nissim Hay
金额:
$20.92万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 2003-07-31

项目摘要

项目成果

Nissim Hay的其他基金

相似基金

相关文献

中文摘要
翻译
血清和某些生长因子促进生存,抑制细胞凋亡;
英文摘要
Serum and certain growth factors promote survival and inhibit apoptosis, but the mechanism by which this is achieved is unclear. Activated forms of Ras, Raf and Src are transforming but do not deliver a survival signal upon serum withdrawal, whereas inhibition of PI3kinase accelerated apoptosis and an activated form of the S/T kinase Akt, a downstream effector of PI3K, blocked apoptosis. The ability of Akt to promote survival was dependent upon its kinase activity. PI3K and Akt appear to be components of a pathway that transduces a survival signal that ultimately blocks Ced3/ICE protease activity. This proposal focusses on delineating the mechanism(s) by which Akt promotes survival concentrating on three aspects. (1) Does Akt deliver a survival signal by inactivating 4E-BP1, the repressor of protein translation? (2) Does Akt intervene in the apoptosis cascade at the level of Bcl-2 family members, integrity of mitochondria, caspase activity or Ced-4/Apaf-1? (3) Does Akt promote survival by increasing cell-cell adhesion and/or intracellular levels of b-catenin via inhibition of GSK3?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hexokinase 2 and cancer therapy
Hexokinase 2 and cancer therapy
Hexokinase 2 and cancer therapy
The role of AMPK and CD36 in breast cancer tumorigenesis and metastasis
  • 批准号:
    10377328
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    Nissim Hay
  • 依托单位:
海外基金